What is Cortechs.ai?
Cortechs.ai is a medical device software company dedicated to revolutionizing quantitative analysis of the human brain. Their proprietary technology automatically segments and quantifies brain structures, transforming complex imaging data into actionable insights for clinical practice. This cutting-edge platform provides neurologists, radiologists, and researchers globally with a convenient and cost-effective tool for assessing a wide spectrum of neurological conditions, including Alzheimer's disease, epilepsy, multiple sclerosis, brain trauma, and developmental abnormalities. The company's focus on making quantitative brain analysis a routine part of clinical care positions it as a key player in the neuroimaging and digital health sectors.
How much funding has Cortechs.ai raised?
Cortechs.ai has raised a total of $3.6M across 3 funding rounds:
Series A
$2M
Series B
$1.2M
Debt
$350K
Series A (2013): $2M, investors not publicly disclosed
Series B (2014): $1.2M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
What's next for Cortechs.ai?
With its recent major enterprise-level funding, Cortechs.ai is poised for accelerated growth and expansion. The strategic investment will likely be directed towards enhancing its software capabilities, broadening its clinical applications, and expanding its market reach into new geographical territories. Further development of its AI-driven analytical tools could solidify its leadership in neurological diagnostics and patient care. The company's trajectory suggests a strong emphasis on scaling operations and potentially exploring new partnerships to integrate its technology into broader healthcare ecosystems.
See full Cortechs.ai company page
